3m earnings release, October 20, 2026

3m Co (MMM) · Form 8-K, Item 2.02 · Filed · SEC filing

3M Reports Third-Quarter 2026 Results; Raises Full-Year EPS Guidance

• Q3 GAAP sales of $6.6 billion, up 1.0%; operating margin of 23.7%, up 150 bps; EPS of $2.63, up 70%, all YoY

◦ Adjusted sales of $6.6 billion with organic growth of 3.3% YoY

◦ Adjusted operating margin of 26.2% on new basis¹, up 110 bps YoY

◦ Adjusted EPS of $2.50 on new basis¹, up 12% YoY

• Q3 operating cash flow of $0.5 billion with adjusted free cash flow of $1.2 billion

• 2026 adjusted EPS guidance raised to $9.10 to $9.15, incorporating new basis¹

ST. PAUL, Minn. – Oct. 20, 2026 − 3M (NYSE: MMM) today reported third-quarter results.

“We delivered another quarter of strong results, including solid sales growth, continued margin expansion, double-digit EPS growth, and robust free cash flow,” said William Brown, 3M Chairman and CEO. “Improving productivity through structural transformation and a stronger pipeline of differentiated technologies reinforce our confidence in the full-year outlook and long-term growth and margin potential. I want to thank the 3M team for their focus on customers and disciplined execution, which continues to strengthen our performance and create shareholder value.”

Third-quarter highlights:

• Adjusted (non-GAAP) reporting updated to treat amortization of intangible assets as a special item for all periods presented; no material year-on-year impact on new basis.

• GAAP EPS of $2.63 and operating margin of 23.7%.

• Adjusted EPS of $2.50, up 12% year-on-year.

• Adjusted operating income margin of 26.2%, up 110 basis points year-on-year.

• Sales of $6.6 billion, up 1.0% year-on-year with organic sales up 0.2% year-on-year.

• Adjusted sales of $6.6 billion, up 4.2% year-on-year with adjusted organic sales up 3.3% year-on-year.

• 3M returned $0.6 billion to shareholders via dividends and share repurchases.

• Cash from operations of $0.5 billion.

• Adjusted free cash flow of $1.2 billion.¹

New basis: Updated non-GAAP reporting treats intangible asset amortization as a special item for all periods presented. The change increases base Q3 adjusted operating income margin by approximately 40 bps and adjusted EPS by approximately $0.04. Year-on-year comparisons are not materially impacted as all periods are reflected on the same basis.¹

Strategic and operational highlights

The following are recently announced highlights:

• 3M entered into an expanded strategic commercial relationship with Amazon to deploy and scale 3M’s optical connectivity and other Data Center related products. 3M issued a warrant to Amazon to purchase up to 3.2 million shares of 3M common stock based upon the achievement of $6 billion in cumulative sales of optical connectivity and other Data Center related products over the next seven years, and other event-based milestones.

• 3M is collaborating with Genius Electronic Optical Co., Ltd. (GSEO), an optical technology company, to advance technology development and manufacturing for 3M's Expanded Beam Optics (EBO) solutions. In support of these efforts, 3M is investing to acquire ~4.7% of GSEO's common shares. The collaboration brings together 3M's EBO technology leadership, optical interconnect expertise, materials science, manufacturing scale and customer relationships with GSEO's precision optics manufacturing capabilities and production scale.

• 3M introduced Cooling Film technology for fleet and rail applications, expanding its portfolio of thermal management solutions for transportation customers. Applied to vehicle roofs, the highly reflective performance film uses thermal management technology to reduce heat buildup and help keep interiors noticeably cooler.

• 3M showcased how its materials science expertise supports innovation in golf equipment through its collaboration with PING. By pairing PING’s expertise in club design and custom manufacturing with 3M’s broad portfolio of materials science solutions, the two companies can collaborate on engineering solutions that turn complex technical challenges into repeatable, high-quality results on the course.

• 3M and BOE established a joint innovation laboratory to accelerate next-generation display technology development. The joint research and development platform brings together BOE’s display innovation and end-use application expertise with 3M’s materials science capabilities to accelerate higher-performance solutions across LCD, OLED and MLED applications, including improvements in light efficiency, foldable displays and ultra-narrow bezel processes.

• 3M continued to expand its work with U.S. and international government customers, with third-quarter awards supporting defense, health care, and emergency response needs. Awards included PELTOR™ communication and hearing protection solutions for various U.S. military services and Scott SCBAs for the U.S. Navy, respirator and SCBA products for the National Institutes of Health, and respirators for international customers, reflecting 3M’s growing work with government partners around the world.

Updated full-year 2026 guidance

3M provided an update to the full-year 2026 guidance provided on July 21, 2026, incorporating the company’s performance year-to-date, the acquisition of Madison Fire & Rescue, and a change in non-GAAP treatment of amortization.

• Adjusted total sales growth² of >4.5 percent, reflecting adjusted organic sales growth² of >3.5 percent.

• Adjusted EPS² of $9.10 to $9.15.

• Adjusted operating cash flow² of ~$5.9 billion with adjusted free cash flow of ~$4.8 billion.²

As further discussed at⁵ within the "Supplemental Financial Information Non-GAAP Measures" sections, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items.

Conference call

3M will conduct an investor teleconference at 9 a.m. ET (8 a.m. CT) today. Investors can access this conference via the following:

Live webcast at https://investors.3M.com

• Webcast replay at https://investors.3m.com/financials/quarterly-earnings²

Financial statements

Income Statement

Third-quarter highlights:

Q3 2026Q3 2025
GAAP EPS2.631.55
Special items:Loss on business divestitures0.3
Special items:(Increase) decrease in value of Solventum ownership-0.60.13
Special items:Net costs for significant litigation and PFAS exit0.190.19
Special items:Transformation costs0.080.02
Special items:Amortization and business acquisition-related costs0.20.04
Special items:Adjusted EPS2.52.23
Memo:GAAP operating income margin23.722.2
Memo:Adjusted operating income margin26.225.1

Income Statement

Three months ended September 30, — (Unaudited)

Three months ended September 30, – 2026Three months ended September 30, – 2025Nine months ended September 30, – 2026Nine months ended September 30, – 2025
Net sales6,5846,51719,11418,815
Operating expensesCost of sales3,8013,79211,19210,916
Operating expensesSelling, general and administrative expenses9218202,7263,032
Operating expensesResearch, development and related expenses304297914870
Operating expensesLoss on business divestitures161343164
Operating expensesTotal operating expenses5,0265,07015,17514,982
Operating expensesOperating income1,5581,4473,9393,833
Operating expensesOther expense (income), net-112300271378
Operating expensesIncome before income taxes1,6701,1473,6683,455
Operating expensesProvision for income taxes261308665818
Operating expensesIncome of consolidated group1,4098393,0032,637
Operating expensesIncome from unconsolidated subsidiaries, net of taxes12451
Operating expensesNet income including noncontrolling interests (NCIs)1,4108413,0072,688
Operating expensesNet income (loss) attributable to NCIs and adjustment to redeemable NCI3774815
Operating expensesNet income attributable to 3M common shareholders1,3738342,9592,673
Earnings per share attributable to 3M common shareholders:Weighted average 3M common shares outstanding — basic518.8534.1522.5538.4
Earnings per share attributable to 3M common shareholders:Earnings per share — basic2.651.565.664.97
Earnings per share attributable to 3M common shareholders:Weighted average 3M common shares outstanding — diluted522.6538.1525.9542.1
Earnings per share attributable to 3M common shareholders:Earnings per share — diluted2.631.555.634.93

Income Statement

Three months ended September 30, — (Unaudited) (in millions)

Three months ended September 30,Three months ended September 30,Nine months ended September 30,Nine months ended September 30,
Safety and Industrial9607922,6422,279
Transportation and Electronics4684841,3711,354
Consumer300292770780
Total reportable business segments1,7281,5684,7834,413
CorporateCorporate-level (expense) income-2173389
Corporate special items:Net costs for significant litigation and PFAS exit-4665-59-356
Corporate special items:Amortization and business acquisition-related costs-64-26-125-78
Corporate special items:(Loss) gain on business divestitures-161-343-164
Corporate special items:Manufactured PFAS products-2-126-57
Corporate special items:Transformation costs-58-14-224-14
Corporate special items:Total Corporate-170-121-844-580
Corporate special items:Total Company operating income1,5581,4473,9393,833
Corporate special items:Other expense/(income), net-112300271378
Corporate special items:Income before income taxes1,6701,1473,6683,455

Income Statement

Three months ended September 30, 2026 — Certain amounts adjusted for special items (non-GAAP measures): (Dollars in millions, except per share amounts)

Three months ended September 30, 2026Three months ended September 30, 2026Three months ended September 30, 2026Three months ended September 30, 2026Three months ended September 30, 2026Three months ended September 30, 2026Three months ended September 30, 2026Three months ended September 30, 2026Three months ended September 30, 2026
Total Company GAAP amounts1,55823.7150 bps1,67026115.71,3732.6370
Corporate GAAP amounts-170
Adjustments for special items:Net costs for significant litigation and PFAS exit4616061990.19
Adjustments for special items:Amortization and business acquisition-related costs6464-141020.2
Adjustments for special items:Solventum ownership - change in value-28132-313-0.6
Adjustments for special items:Transformation costs585813450.08
Adjustments for special items:Total special items168192-67-0.13
Adjustments for special items:Total Company adjusted amounts (non-GAAP measures)41,72626.2110 bps1,67135321.11,3062.512
Adjustments for special items:Corporate adjusted amounts (non-GAAP measures)4-2

Income Statement

(Unaudited)

2026 forecast
2026 adjusted operating income margin expansion (non-GAAP measure)4,52026 adjusted earnings per share (non-GAAP measure)4,5$9.10 to $9.15
2026 adjusted operating income margin expansion (non-GAAP measure)4,52026 adjusted effective tax rate (non-GAAP measure)4,5~20%

Balance Sheet

September 30, 2026 — (Unaudited)

September 30, 2026December 31, 2025
Current assetsCash and cash equivalents4,8355,235
Current assetsMarketable securities310698
Current assetsAccounts receivable – net4,1163,533

Cash Flow

Nine months ended September 30, — (Unaudited)

Nine months ended September 30, – 2026Nine months ended September 30, – 2025
Net cash provided by (used in) operating activities2,046723
Cash flows from investing activities:Purchases of property, plant and equipment-704-662
Cash flows from investing activities:Acquisitions, net of cash acquired-1,910
Cash flows from investing activities:Purchases and proceeds from sale or maturities of marketable securities and investments – net3902,346
Cash flows from investing activities:Proceeds from (payments for) sale of businesses, net of cash sold-3265
Cash flows from investing activities:Other investing activities3866
Cash flows from investing activities:Net cash provided by (used in) investing activities-2,5121,755
Cash flows from financing activities:Change in debt – net2,525-705
Cash flows from financing activities:Purchases of treasury stock and dividends paid to shareholders-4,441-3,874
Cash flows from financing activities:Proceeds from issuances of treasury stock pursuant to stock option and benefit plans7021,219
Cash flows from financing activities:Proceeds from investment by noncontrolling interest1,277
Cash flows from financing activities:Other financing activities-38-39
Cash flows from financing activities:Net cash provided by (used in) financing activities25-3,399
Cash flows from financing activities:Effect of exchange rate changes on cash and cash equivalents-536
Cash flows from financing activities:Net increase (decrease) in cash and cash equivalents, including cash classified within assets held for sale-446-885
Cash flows from financing activities:Less: net increase (decrease) in cash classified within assets held for sale-4644
Cash flows from financing activities:Net increase (decrease) in cash and cash equivalents-400-929
Cash flows from financing activities:Cash and cash equivalents at beginning of year5,2355,600
Cash flows from financing activities:Cash and cash equivalents at end of period4,8354,671

Cash Flow

Three months ended September 30, (in millions)

Three months ended September 30, – 2026Three months ended September 30, – 2025Nine months ended September 30, – 2026Nine months ended September 30, – 2025
Net cash provided by (used in) operating activities4861,7562,046723
Net cash provided by (used in) investing activities-2,089465-2,5121,755
Net cash provided by (used in) financing activities3,483-1,20825-3,399

Cash Flow

Three months ended September 30, — (Unaudited) (in millions)

Three months ended September 30, – 2026Three months ended September 30, – 2025Nine months ended September 30, – 2026Nine months ended September 30, – 2025
Net cash provided by (used in) operating activities4861,7562,046723
Adjustments for special items:Net costs/(recoveries) for significant litigation and PFAS exit after-tax payment impacts894-2001,5772,803
Adjustments for special items:Divestiture costs after-tax payment impacts2685
Adjustments for special items:TCJA transition tax payment211
Adjustments for special items:Business acquisition-related costs2323
Adjustments for special items:Transformation actions after-tax payment impacts5093
Adjustments for special items:Manufactured PFAS products after-tax payment impacts-6051-92
Adjustments for special items:Total adjustments for special items967-2341,7443,007
Adjustments for special items:Adjusted net cash provided by (used in) operating activities (non-GAAP measure)61,4531,5223,7903,730
Adjustments for special items:Purchases of property, plant and equipment (PPE)-256-218-704-662
Adjustments for special items:Manufactured PFAS products impact - removing related purchases of PPE615
Adjustments for special items:Adjusted purchases of PPE (non-GAAP measure)6-256-212-704-647
Adjustments for special items:Adjusted free cash flow (non-GAAP measure)61,1971,3103,0863,083

Cash Flow

Year ended December 31, — (Unaudited) (in millions)

Year ended December 31, – 2025Year ended December 31, – 2024
Net cash provided by (used in) operating activities2,3061,819
Adjustments for special items:Net costs/(recoveries) for significant litigation after-tax payment impacts2,8173,831
Adjustments for special items:Divestiture costs and divestiture-related restructuring after-tax payment impacts102374

Cash Flow (in billions)

2026 forecast
Net cash provided by (used in) operating activities~$5.9
Adjusted net cash provided by (used in) operating activities (non-GAAP measure)5,6~$5.9
Purchase of property, plant and equipment (PPE)~$1.1
Adjusted free cash flow (non-GAAP measure)5,6~$4.8
Full release

Forward-looking statements

Certain statements in this document, as well as other filings we make with the United States Securities and Exchange Commission (“SEC”) and other written and oral information we release are considered "forward-looking statements" under the federal securities laws, including the Private Securities Litigation Reform Act of 1995, as amended ("PSLRA"). Forward-looking statements may appear throughout this document and are typically identified by the words "aim," "anticipate," "believe," "can," "continue," "could," "estimate," "evaluate," "expect," "forecast," "future," "goal," "guidance," "impact," "initial," "intend," "likely," "may," "outlook," "plan," "possible," "potential," "predict," "probable," "project," "seek," "should," "strategy," "target," "will," "would," and other words that are similar to, or have the opposite meanings of, those words.

All forward-looking statements are intended to enjoy the protection of the PSLRA’s safe harbor for forward-looking statements, as well as the protections provided by other securities laws. Forward-looking statements speak only as of the date they are made and the Company assumes no obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on any of these forward-looking statements.

Although the Company believes it has a reasonable basis for the forward-looking statements it makes, those statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Changes in those assumptions, expectations, or other factors could produce materially different results. The most important risks, uncertainties, and other factors that could cause the Company's actual results to differ from the Company's forward-looking statements include: (1) worldwide economic, political, regulatory, international trade, geopolitical, tariffs, and retaliatory countermeasures, capital markets, and other external conditions, (2) foreign currency exchange rates and fluctuations in those rates, (3) liabilities and contingencies related to PFAS, including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's exit of PFAS manufacturing and work to discontinue use of PFAS across its product portfolio, (4) risks related to the PWS Settlement to resolve claims by public water suppliers in the United States regarding PFAS, as well as risks related to ongoing PFAS-related settlements and claims, (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q, and 8-K, as well as compliance risks related to legal or regulatory requirements, government contract requirements, policies and practices, or other matters that require or encourage the Company or its customers, suppliers, vendors, or channel partners to conduct business in a certain way, (6) competitive conditions and customer preferences, (7) the timing and market acceptance of new product and service offerings, (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, tariffs, supply chain interruptions, or natural or other disasters, (9) unanticipated problems or delays when implementing new business systems and solutions, including with the phased implementation of a global enterprise resource planning system, or security breaches and other disruptions to the Company's information or operational technology infrastructure, (10) use of artificial intelligence technologies, (11) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies, (12) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities, (13) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans, (14) the Company’s credit ratings and its cost of funding, (15) tax-related external conditions, including changes in tax rates, laws, or regulations, (16) matters relating to the Company's Aearo Entities, Combat Arms Earplugs Settlement, and related products, and (17) matters relating to the spin-off of Solventum, the Company's former Health Care business, into an independent public company.

Those risks, uncertainties, and other factors are further described in Part I, Item 1A, "Risk Factors" of the Company's Form 10-K for the year ended December 31, 2025. For additional information concerning factors that may cause actual results to differ materially from the Company's forward-looking statements, see the Company's reports on Form 10-K, 10-Q, and 8-K filed with the SEC from time to time.³

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · 3m earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.